001), and PMCA histopathologic subtype ( P <. 001), prior chemotherapy treatment ( P =. 006), major postoperative complications ( P <. 030) as independent predictors for a poorer progression-free survival. 013), debulking surgery (completeness of cytoreduction, 2 or 3 P <.
008), high peritoneal cancer index ( P =. 001), major postoperative complications ( P =. 001), peritoneal mucinous carcinomatosis (PMCA) histopathologic subtype ( P <. Multivariate analysis identified prior chemotherapy treatment ( P <. The median survival rate was 196 months (16.3 years) and the median progression-free survival rate was 98 months (8.2 years), with 10- and 15-year survival rates of 63% and 59%, respectively. Treatment-related mortality was 2% and major operative complications occurred in 24% of patients. Two thousand two hundred ninety-eight patients from 16 specialized units underwent CRS for PMP. Pelz, University of Wuerzburg, Wuerzburg and Pompiliu Piso, University Medical Center Regensburg, Regensburg, Germany.
Ceelen, University Hospital, Ghent Kurt Van Der Speeten, Ziekenhuis Oost-Limburg, Genk, Belgium Joerg O. de Hingh, Catharina Hospital, Eindhoven, the Netherlands Wim P. Gilly, Centre Hospitalo-Universitaire Lyon Sud, Hospices Civils de Lyon, Pierre Bénite Dominique Elias, Institut Gustave Roussy Cancer Center, Villejuif, France Dario Baratti and Marcello Deraco, National Cancer Institute, Milan, Italy Armando Sardi, Institute for Cancer Care, Mercy Medical Center, Baltimore, MD Pedro Barrios, Hospital Sant Joan Despí Moises Broggi, Barcelona Alberto Gómez Portilla, Hospital Santiago Apostol, Vitoria Santiago González-Moreno, MD Anderson Cancer Center Madrid, Madrid, Spain Ignace H.J.T. Levine, Wake Forest University Baptist Medical Center, Winston-Salem, NC Olivier Glehen and François N. Yan, Washington Cancer Institute, Washington Hospital Center, Washington, DC Edward A. Moran, Basingstoke and North Hampshire National Health Service Foundation Trust, Basingstoke, United Kingdom Paul H. Morris, University of New South Wales, St George Hospital, Sydney, Australia Brendan J.
0 kommentar(er)
